KCAS Bio is happy to announce our participation in the 17th EBF Open Symposium, taking place in Barcelona, Spain, from November 20-22, 2024. This prestigious event is a cornerstone for professionals in bioanalysis, offering a platform to share cutting-edge research, innovative methodologies, and industry best practices. We are thrilled to be part of this vibrant community and look forward to showcasing our advanced bioanalytical capabilities.
The field of bioanalysis is continually evolving, and KCAS Bio is at the forefront of innovation. We specialize in developing and implementing advanced analytical techniques that address the complex challenges of drug development. Our expertise in high-resolution mass spectrometry, liquid chromatography-mass spectrometry, and multiplex assays enables us to deliver high-quality results with exceptional precision. We are dedicated to driving scientific progress through continuous improvement and the application of cutting-edge technologies.
Collaboration is essential for advancing bioanalytical science, and at KCAS Bio, we believe in the power of partnership. The 17th EBF Open Symposium provides an excellent opportunity for us to engage with industry leaders, researchers, and potential collaborators. We look forward to exploring new opportunities for partnership that can lead to innovative solutions and accelerated drug development.
Don’t miss out on these podium and poster presentations from KCAS Bio :
– Hybrid LC-MS/MS Technology Becoming Increasingly Valuable in the Bioanalysis of Antibody Drug Conjugates – Bioanalytical Strategy Illustrated by Case Studies
by Dominic Warrino, PhD
Session 9a – Nov 21 – 9:40 am
– Refining Method Development & Validation Testing for Antibody Drug Conjugate Payloads
by John Perkins, PhD
Session 12b – Nov 21 – 3:10 pm
– Validation of a 15-Color Spectral Flow Cytometry Panel for Reliable and Comprehensive Leukocyte Profiling in Human Whole Blood for Translational and Clinical Applications
by Mouhssin OUFIR, PhD
Poster Presentation
– Comparative Evaluation of Ligand Binding Assay Platforms for Biomarker Quantification: Critical Considerations for Ensuring Data Quality and Project Success
by Fabien Lavocat, MSc
Poster Presentation
We invite all attendees to visit us at our booth (B21) during the 17th EBF Open Symposium. Engage with our team, discuss your projects, and discover how KCAS Bio can support your bioanalytical needs. We will be showcasing our latest projects, discussing industry trends, and exploring how our innovative solutions can benefit your drug development programs. Reach out to schedule a meeting at the conference today and join us in Barcelona for an event that promises to shape the future of bioanalysis.